CARA THERAPEUTICS INC (CARA)
US1407551092 - Common Stock
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
STAMFORD, Conn., April 02, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new...
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
STAMFORD, Conn., March 07, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new...
7 F-Rated Stocks to Sell in March 2024
This market is too strong to risk holding F-rated stocks. If you're still seeing these names in your portfolio, it's time to make a move.
CARA Stock Earnings: Cara Therapeutics Misses EPS, Misses Revenue for Q4 2023
CARA stock results show that Cara Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
CARA Stock Earnings: Cara Therapeutics Misses EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cara Therapeutics (NASDAQ:CARA) just reported results for the fourth quarter of...
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
–Announced prioritization of clinical programs to focus on late-stage development of oral difelikefalin for notalgia paresthetica (NP)– –Completed...
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.